{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:33:55Z","timestamp":1792020835371,"version":"4.4.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>We aimed to evaluate the efficacy of gentamicin compared to corticosteroids for the treatment of Meniere\u2019s disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An extensive search was conducted in PubMed, Embase, and Web of Science until May 2024. For continuous outcomes, pooled effect estimates were determined by calculating the weighted mean difference (WMD), while for binary outcomes, the risk ratio (RR) was used, each accompanied by their respective 95% confidence intervals (CIs). Heterogeneity among the studies was assessed using Cochran\u2019s <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> and <jats:italic>Q<\/jats:italic> statistics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 12 studies were selected, involving 694 patients. Our analysis found that the gentamicin group demonstrates superior vertigo control rates compared to the corticosteroid group (RR: 1.36, 95% CI: 1.13 to 1.65, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). In subgroup analysis, the gentamicin group showed a higher vertigo control rates at 6\u2009months compared to the corticosteroid group (RR: 1.69, 95% CI: 1.28 to 2.24, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001); however, there was no statistically significant difference between the two groups at 12\u2009months (RR: 1.48, 95% CI: 0.88 to 2.49, <jats:italic>p<\/jats:italic>\u2009=\u20090.14). Regarding changes in pure tone average, the corticosteroid group was superior to the gentamicin group (WMD: 4.41, 95% CI: 3.31 to 5.52, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study suggests that the intratympanic gentamicin group achieves higher vertigo control rates, whereas the corticosteroid group demonstrates better improvement in pure tone averages. However, the high heterogeneity in vertigo control rates warrants caution. Larger sample-sized randomized controlled trials are needed to further validate these findings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1471010","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:29:57Z","timestamp":1726115397000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparative efficacy of intratympanic gentamicin and intratympanic corticosteroid in the treatment of Meniere\u2019s disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Xuanmei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"116972","DOI":"10.1016\/j.envres.2023.116972","article-title":"Meniere\u2019s disease: pathogenesis, treatments, and emerging approaches for an idiopathic bioenvironmental disorder","volume":"238","author":"Mohseni-Dargah","year":"2023","journal-title":"Environ Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000490274","article-title":"Meniere\u2019s Disease","volume":"82","author":"Gibson","year":"2019","journal-title":"Adv Otorhinolaryngol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102817","DOI":"10.1016\/j.amjoto.2020.102817","article-title":"Meniere\u2019s disease: medical management, rationale for vestibular preservation and suggested protocol in medical failure","volume":"42","author":"Christopher","year":"2021","journal-title":"Am J Otolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s0030-6665(02)00019-1","article-title":"Etiology, pathophysiology of symptoms, and pathogenesis of Meniere\u2019s disease","volume":"35","author":"Paparella","year":"2002","journal-title":"Otolaryngol Clin N Am"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11940-015-0341-x","article-title":"Treatment of Meniere\u2019s disease","volume":"17","author":"Sharon","year":"2015","journal-title":"Curr Treat Options Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599820909438","article-title":"Clinical practice guideline: M\u00e9ni\u00e8re\u2019s disease","volume":"162","author":"Basura","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/00016489.2019.1657240","article-title":"Current state of evidence for endolymphatic sac surgery in Meni\u00e8re\u2019s disease: a systematic review","volume":"139","author":"Devantier","year":"2019","journal-title":"Acta Otolaryngol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e0237523","DOI":"10.1371\/journal.pone.0237523","article-title":"Pharmacologic and surgical therapies for patients with Meniere\u2019s disease: a systematic review and network meta-analysis","volume":"15","author":"Ahmadzai","year":"2020","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/0194599818803612","article-title":"Quality-of-life outcomes following surgical treatment of M\u00e9ni\u00e8re\u2019s disease: a systematic review and meta-analysis","volume":"160","author":"Ballard","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"810352","DOI":"10.3389\/fneur.2022.810352","article-title":"A comparison of local endolymphatic sac decompression, endolymphatic mastoid shunt, and wide endolymphatic sac decompression in the treatment of intractable Meniere's disease: a short-term follow-up investigation","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/S0140-6736(16)31461-1","article-title":"Intratympanic methylprednisolone versus gentamicin in patients with unilateral M\u00e9ni\u00e8re\u2019s disease: a randomised, double-blind, comparative effectiveness trial","volume":"388","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1007\/s12070-021-02528-6","article-title":"Comparing intratympanic gentamicin with methylprednisolone in Meniere\u2019s disease with non-serviceable hearing","volume":"74","author":"Thomas","year":"2021","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00405-015-3689-3","article-title":"Intratympanic corticosteroids injections: a systematic review of literature","volume":"273","author":"Lavigne","year":"2016","journal-title":"Eur Arch Otorrinolaringol"},{"key":"ref14","volume-title":"Efficacy of low dose of Intratympanic gentamicin in Meniere\u2019s disease: [dissertation\/master\u2019s thesis]","author":"Babu","year":"2006"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/lary.27392","article-title":"Intratympanic therapies in M \u00e9ni\u00e8re disease: evaluation of outcomes and early Vertigo control","volume":"129","author":"Naples","year":"2019","journal-title":"Laryngoscope"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1067\/mhn.2001.119485","article-title":"Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease","volume":"125","author":"Sennaroglu","year":"2001","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1007\/s00415-020-10011-5","article-title":"What is the efficacy of gentamicin on the incidence of vertigo attacks and hearing in patients with Meniere's disease compared with steroids? A meta-analysis","volume":"268","author":"Jiang","year":"2021","journal-title":"J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00415-020-10320-9","article-title":"Effects of intratympanic gentamicin and intratympanic glucocorticoids in M\u00e9ni\u00e8re\u2019s disease: a network meta-analysis","volume":"269","author":"Hao","year":"2022","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e934475","DOI":"10.12659\/MSM.934475","article-title":"Review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines","volume":"27","author":"Parums","year":"2021","journal-title":"Med Sci Monitor Int Med J Exp Clin Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/j.pain.0000000000001469","article-title":"Adequate and complete reporting of Cochrane risk of bias tool","volume":"160","author":"Puljak","year":"2019","journal-title":"Pain"},{"key":"ref21","volume-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"ref22","first-page":"71","article-title":"Menieres\u2019 disease symptomatology in relation to the AAO-HNS 1995 guidelines","volume":"64","author":"Albera","year":"2014","journal-title":"OTORINOLARINGOLOGIA"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/bmj.h1435","article-title":"Meta-analyses: what is heterogeneity?","volume":"350","author":"Sedgwick","year":"2015","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1515\/ijb-2022-0070","article-title":"Heterogeneity in meta-analysis: a comprehensive overview","volume":"20","author":"Stogiannis","year":"2024","journal-title":"Int J Biostat"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e841","DOI":"10.1371\/journal.pone.0000841","article-title":"Heterogeneity in meta-analyses of genome-wide association investigations","volume":"2","author":"Ioannidis","year":"2007","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajodo.2020.07.002","article-title":"Exploring heterogeneity in meta-analysis: Meta-regression analysis","volume":"158","author":"Spineli","year":"2020","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/1469-0691.12494","article-title":"The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses","volume":"20","author":"Melsen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.13201\/j.issn.1001-1781.2017.02.004","article-title":"Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere\u2019s disease","volume":"31","author":"Wang","year":"2017","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/indianjotol.INDIANJOTOL_73_20","article-title":"A retrospective comparison of Intratympanic dexamethasone with gentamicin in Meniere\u2019s disease\u2014a single-institutional study","volume":"26","author":"Manimaran","year":"2020","journal-title":"Ind J Otol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/0194599811429432","article-title":"Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial","volume":"146","author":"Casani","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref32","first-page":"1781","article-title":"Clinical effect of prootic and opisthotic injection of dexamethasone and gentamicin in meniere disease therapy","volume":"15","author":"Guo","year":"2016","journal-title":"Trop J Pharm Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/0194599812472882","article-title":"The effect of intratympanic methylprednisolone and gentamicin injection on Meniere\u2019s disease","volume":"148","author":"Gabra","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref34","first-page":"193","article-title":"Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing","volume":"16","author":"Akkuzu","year":"2006","journal-title":"Kulak Burun Bogaz Ihtisas Dergisi: KBB Journal of Ear, Nose, and Throat"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.7123\/01.EJO.0000418018.88180.0c","article-title":"Intratympanic injection in Meniere\u2019s disease; symptomatic and audiovestibular; comparative, prospective randomized 1-year control study","volume":"28","author":"ElBeltagy","year":"2012","journal-title":"Egypt J Otolaryngol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.13005\/bpj\/772","article-title":"Comparison the efficacy of intratympanic injections of methylprednisolone and gentamicin to control vertigo in unilateral M\u00e9ni\u00e8re\u2019s disease","volume":"8","author":"Sarafraz","year":"2015","journal-title":"Biomed Pharmacol J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11798\/j.issn.1007-1520.202423362","article-title":"Clinical practice guidelines for tympanic administration(in Chinese)","volume":"30","author":"Cai","year":"2024","journal-title":"Chin J Otorhinolaryngol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/00016489850183359","article-title":"Intratympanic gentamicin in Meniere\u2019s disease","volume":"118","author":"Kaasinen","year":"1998","journal-title":"Acta Otolaryngol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e0158806","DOI":"10.1371\/journal.pone.0158806","article-title":"Gentamicin exposure and sensorineural hearing loss in preterm infants","volume":"11","author":"Fuchs","year":"2016","journal-title":"PLoS One"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1471010\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:30:07Z","timestamp":1726115407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1471010\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":39,"alternative-id":["10.3389\/fneur.2024.1471010"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1471010","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"article-number":"1471010"}}